The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2020 / Feb / Biopharma's Big Transformation
Manufacture Bioprocessing Biopharma Facilities & Equipment Technology & Manufacturing Sponsored

Biopharma's Big Transformation

From digital technology to data analytics to continuous bioprocessing; the world of biopharma manufacturing is changing rapidly

02/27/2020 1 min read

Sponsored By

Cytiva

Share

In May 2019, Cytiva brought experts together at its Uppsala, Sweden, site for Bioprocess Days: an event to discuss the future of bioprocessing. Key themes involved digital technology, data and analytics, continuous processing, advanced medicine and more. This eBook includes insight from a range of speakers who attended the event, including Jun Huang from Pfizer, Wei Gong from Henlius Biotech, and Carol Knevelman from Oxford Biomedica. We also catch up with Cytiva’s Günter Jagschies.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Breaking Manufacturing Bottlenecks in Nucleic Acid Therapeutics
Biopharma Biopharma
Breaking Manufacturing Bottlenecks in Nucleic Acid Therapeutics

August 31, 2026

4 min read

New approaches to oligonucleotide production, mRNA design, and supply chain control could help turn promising nucleic acid therapies into scalable commercial products

The Hidden Complexity of Stability Storage
Biopharma Technology & Manufacturing
The Hidden Complexity of Stability Storage

August 27, 2026

9 min read

Why preserving samples is a scientific, regulatory, and operational challenge – and what’s at risk when it goes wrong

Green Shoots, Gray Skies
Biopharma Interviews Business & Trends
Green Shoots, Gray Skies

August 26, 2026

9 min read

Jon Rees sees signs of recovery following biotech's post-pandemic funding reset, but there’s no going back to the “old normal”

Phase III Success Marks Milestone for Personalized Cancer Vaccines
Biopharma Industry News Development & Clinical
Phase III Success Marks Milestone for Personalized Cancer Vaccines

August 26, 2026

7 min read

Merck and Moderna report positive phase III results for intismeran in melanoma, as The Medicine Maker revisits how cancer vaccines work and the challenges still facing the field

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: